Skip to content

The efficacy of exercise training and nutritional supplementation in prostate cancer survivors

The efficacy of resistance exercise training and nutritional supplementation of calcium, vitamin D and protein on musculoskeletal health, cardiometabolic risk factors and health-related quality of life in prostate cancer survivors treated with androgen deprivation therapy when compared to usual care

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12614000317695
Acronym
IMPACT
Enrollment
70
Registered
2014-03-25
Start date
2014-08-01
Completion date
2017-11-29
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The aim of this study is to evaluate the efficacy of resistance exercise training and nutritional supplementation in prostate cancer survivors treated with androgen deprivation therapy. Who is it for? You may be eligible to join this study if you are a male aged 50-85 years and are currently undergoing treatment for prostate cancer with androgen deprivation therapy which is expected to continue for at least 52 weeks. Study details Participants in this study will be randomly (by chance) allocated to one of two groups. Participants in one group will participate in an individually tailored progressive resistance exercise training program three times a week and receive daily supplementation of calcium, vitamin D and protein over a period of 52 weeks. Participants in the other group will receive the usual care administered to men undergoing androgen deprivation therapy. Participants will be assessed at baseline, 26 weeks and 52 weeks in order to determine any changes in musculoskeletal health, cardiometabolic risk factors, and health-related quality of life. Assessment is by bone scans, blood tests, and questionnaires. The results of this study may contribute to the development of exercise and nutritional guidelines for optimising overall health in men treated with androgen deprivation therapy.

Interventions

A randomised controlled trial in which participants treated with androgen deprivation therapy for prostate cancer will participant in progressive resistance exercise training program and daily supplementation of calcium, vitamin D and protein for 52 weeks. The exercise training program will be individually tailored and follow the key training principles of specificity, progressive overload and periodisation. Participants will attend two gym-based training sessions per week and complete one home-

A randomised controlled trial in which participants treated with androgen deprivation therapy for prostate cancer will participant in progressive resistance exercise training program and daily supplementation of calcium, vitamin D and protein for 52 weeks. The exercise training program will be individually tailored and follow the key training principles of specificity, progressive overload and periodisation. Participants will attend two gym-based training sessions per week and complete one home-based training session. For the first 26 weeks, both gym-based training sessions will be supervised by a student exercise physiologist supervised by an accredited exercise physiologist. After 26 weeks, only one gym-based training session will be supervised and the participant will be instructed to perform the other gym-based session unsupervised. Each session will last approximately 60 minutes. Participants will perform resistance, weight-bearing impact and functional exercises. Participants will perform resistance exercises in two sets of 8-15 repetitions at a weight that cannot be lifted more than 8-15 times. Participants will perform weight-bearing impact exercises in three sets of 10-20 repetitions. Participants will perform functional exercises for 30-60 seconds or until fatigue. To enhance benefits from the exercise training program, participants will also consume a nutritional supplement of approximately 500-600mg calcium, 2000IU vitamin D and 20-25g protein daily. The supplement will be administered via a combination of a powder based supplement (mixed with water) and oral capsule. Compliance with the gym-based exercise training program will be assessed via the training notes kept by the participant's trainer. Compliance with the home-based exercise training program will be assessed via an exercise diary (which will be regularly assessed by the participant's trainer). Compliance with the supplement will be assessed via a supplement compliance calendar (which will be regularly assessed by the participant's trainer and/or other researchers). Additionally, all non-consumed supplements will be returned to the researchers and compliance will assessed to ensure it matches the compliance calendar.

Sponsors

Deakin University
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
Male
Age
50 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

Men aged 50-85 years currently undergoing treatment for prostate cancer with androgen deprivation therapy. Treatment with androgen deprivation therapy must be planned to be continuous, pharmacological, administered for greater than three months at enrollment and expected to be administered for the duration of the intervention (52 weeks). All participants in the study must also have received approval from their local physician to participate in the study.

Exclusion criteria

Exclusion criteria: do not have the ability to complete surveys in the English language; any disorder known to affect bone, calcium or vitamin D metabolism (other than hypogonadism); currently receiving pharmacological intervention known to affect bone metabolism (other than androgen deprivation therapy); supplementation with protein, calcium (>600 mg/d) or vitamin D (>1000 IU/d) in the past three months; have undertaken progressive resistance training (>1 session/wk) or high impact weight bearing exercise (>150 min/wk) in the past three months; current smokers; weight greater than 159kg; have plans to travel for greater than six weeks continuously within the following 52 weeks; any absolute contraindications to exercise training according to the American College of Sports Medicine guidelines.

Outcome results

None listed

Source: ANZCTR · Data processed: Mar 8, 2026